ONCOLOGY

Role of Endoscopic Ultrasonography and Endoscopic Retrograde Cholangiopancreatography in the Clinical Assessment of Pancreatic Neoplasms

Sep 27, 2017 by in ONCOLOGY Comments Off on Role of Endoscopic Ultrasonography and Endoscopic Retrograde Cholangiopancreatography in the Clinical Assessment of Pancreatic Neoplasms

Accurate diagnosis and staging of pancreatic neoplasms is essential for surgical planning and identification of locally advanced and metastatic disease that is incurable by surgery. The ability to position the…

read more

Molecular and Genetic Basis of Pancreatic Carcinogenesis

Sep 27, 2017 by in ONCOLOGY Comments Off on Molecular and Genetic Basis of Pancreatic Carcinogenesis

Carcinogenic progression in the pancreas arises through a well-established stepwise accumulation of molecular aberrations from a normal cell to an invasive adenocarcinoma. Recent large-scale sequencing efforts have provided insight into…

read more

Pancreatic Neoplasms

Sep 27, 2017 by in ONCOLOGY Comments Off on Pancreatic Neoplasms

Nicholas J. Petrelli, MD, FACS, Consulting Editor This issue of the Surgical Oncology Clinics of North America is devoted to pancreatic neoplasms. The guest editor is Nipun Merchant, MD. Dr…

read more

Thoracoscopic Lobectomy for Non–small Cell Lung Cancer

Sep 27, 2017 by in ONCOLOGY Comments Off on Thoracoscopic Lobectomy for Non–small Cell Lung Cancer

Lobectomy is the gold standard treatment in operable patients with surgically resectable non–small cell lung cancer. Thoracoscopic lobectomy has emerged as an option for surgeons facile with the technique. Video-assisted…

read more

Local Therapy Indications in the Management of Patients with Oligometastatic Non–Small Cell Lung Cancer

Sep 27, 2017 by in ONCOLOGY Comments Off on Local Therapy Indications in the Management of Patients with Oligometastatic Non–Small Cell Lung Cancer

Advances in surgical, radiation, and interventional radiology therapies carry a reduction in morbidity associated with therapy. Aggressive management of patients with oligometastatic non–small cell lung cancer offers the potential for…

read more

Targeted Therapy and Immunotherapy for Lung Cancer

Sep 27, 2017 by in ONCOLOGY Comments Off on Targeted Therapy and Immunotherapy for Lung Cancer

Targeted therapy and immunotherapy have changed the treatment paradigm of non–small cell lung cancer (NSCLC). Distinct molecular subtypes of NSCLC have been described over the past 20 years, enabling the emergence…

read more

Neoadjuvant Therapy in Non–Small Cell Lung Cancer

Sep 27, 2017 by in ONCOLOGY Comments Off on Neoadjuvant Therapy in Non–Small Cell Lung Cancer

Locally advanced (stage IIIA) non–small cell lung cancer (NSCLC) is confined to the chest, but requires more than surgery to maximize cure. Therapy given preoperatively is termed neoadjuvant , whereas…

read more
Get Clinical Tree app for offline access